Medicinova (MNOV) Total Current Liabilities (2010 - 2025)
Medicinova's (MNOV) quarterly Total Current Liabilities came in at $3.8 million in Q4 2025, up 28.33% year-on-year from $3.0 million in Q4 2024, and up 13.78% on a QoQ basis from $3.3 million in Q3 2025.
Medicinova (MNOV) Total Current Liabilities (2010 - 2025) Analysis & Trends
Medicinova (MNOV) has 16 years of Total Current Liabilities data on file, last reported at $3.8 million in Q4 2025.
- On a quarterly basis, Total Current Liabilities rose 28.33% year-over-year to $3.8 million in Q4 2025; TTM through Dec 2025 was $3.8 million, a 28.33% increase from a year earlier, with the FY2025 full-year figure at $3.8 million, up 28.33% from the prior year.
- Total Current Liabilities for Q4 2025 stood at $3.8 million, up from $3.3 million in the prior quarter.
- Over the last five years, Total Current Liabilities for MNOV reached as high as $4.5 million in Q3 2022 and fell as low as $1.8 million in Q1 2021.
- Historically, Total Current Liabilities has averaged $3.0 million across 5 years, with a median of $2.8 million in 2021.
- Across the five-year window, Total Current Liabilities soared 132.9% in 2021 and slumped 38.13% in 2023, its largest moves.
- Year by year, Total Current Liabilities stood at $2.8 million in 2021, then increased by 12.52% to $3.2 million in 2022, then grew by 2.88% to $3.3 million in 2023, then decreased by 9.76% to $3.0 million in 2024, then increased by 28.33% to $3.8 million in 2025.
- Per Business Quant data, the three most recent Total Current Liabilities figures were $3.8 million in Q4 2025, $3.3 million in Q3 2025, and $2.6 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 56.01 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 66.94 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1.81 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 6.38 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 3.88 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 5.11 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.58 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 289.60 Mn |
| 10 | Medicinova | 64.48 Mn | 64.48 Mn | 4,754.00 | 3.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 3.80 Mn |
| Sep 30, 2025 | 3.34 Mn |
| Jun 30, 2025 | 2.65 Mn |
| Mar 31, 2025 | 2.13 Mn |
| Dec 31, 2024 | 2.96 Mn |
| Sep 30, 2024 | 2.60 Mn |
| Jun 30, 2024 | 2.49 Mn |
| Mar 31, 2024 | 2.51 Mn |
| Dec 31, 2023 | 3.28 Mn |
| Sep 30, 2023 | 2.80 Mn |
| Jun 30, 2023 | 2.82 Mn |
| Mar 31, 2023 | 2.72 Mn |
| Dec 31, 2022 | 3.19 Mn |
| Sep 30, 2022 | 4.53 Mn |
| Jun 30, 2022 | 3.84 Mn |
| Mar 31, 2022 | 2.98 Mn |
| Dec 31, 2021 | 2.83 Mn |
| Sep 30, 2021 | 4.20 Mn |
| Jun 30, 2021 | 2.47 Mn |
| Mar 31, 2021 | 1.83 Mn |